Analysis published in ASN, highlighted compelling evidence that ERAs offer substantial therapeutic benefits for CKD patients.
Phase 2 study met its primary endpoint, demonstrating statistically significant improved overall survival with elraglusib plus ...
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer Newly diagnosed patients with cT2-4N0-2M0 HNC were ...
MADRID, Aug. 31, 2025 /PRNewswire/ --Johnson & Johnson (NYSE: JNJ) – Late breaking clinical science data, presented at the European Society of Cardiology (ESC) Congress today and simultaneously ...
Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...
News-Medical.Net on MSN
Trial finds no benefit of anti-inflammatory therapy in trachomatous trichiasis surgery
John Kempen, MD, MPH, PhD, MHS, Director of Epidemiology for Ophthalmology at Mass Eye and Ear and Harvard Medical School, is ...
6don MSN
Graded sensorimotor retraining shows similar benefits to all people with chronic low back pain
New research has found that the benefits of graded sensorimotor retraining are likely to be similar for all patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results